New to Meducation?
Sign up
Already signed up? Log In
view moderators

MassScreening

Category

Preview
0
0

Screening for HIV infection

Worldwide, approximately 37 million people are infected with HIV and approximately 46% of infections remain undiagnosed.1 The proportion of undiagnosed cases is lower in industrialized countries, although the burden of people living with undiagnosed infection remains substantial. For example, approximately 13% of the 1.2 million people living with HIV in the United States do not have a diagnosis.2 Moreover, people without a diagnosis contribute disproportionately to transmission of the virus, accounting for about 30% of HIV transmissions.3  
feeds.bmj.com
over 4 years ago
Preview
0
0

Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial

Study question What is the effect of default test offers—opt-in, opt-out, and active choice—on the likelihood of acceptance of an HIV test among patients receiving care in an emergency department?  
feeds.bmj.com
over 4 years ago
Preview
0
0

Does Early Screening Reduce Deaths From Ovarian Cancer? CME/CE

: Annual ovarian cancer screening appeared to reduce mortality by 20%, but longer follow-up is needed to determine efficacy and cost-effectiveness.  
medscape.org
over 4 years ago
Preview
0
0

Screening of Diabetics for NAFLD and Advanced Fibrosis

What types of non-invasive screening methods are available for NAFLD and liver fibrosis in diabetic patients, and how safe and effective are they?  
medscape.com
over 4 years ago
Preview
0
0

Opt-Out Screening Can Improve Acceptance of HIV Testing

How providers offer patients an HIV test significantly affects the likelihood of them accepting tests, according to a new study.  
medscape.com
over 4 years ago
Preview
0
0

Rubella screening to end in England - BBC News

Pregnant women will no longer have rubella screening in England, officials announce.  
bbc.co.uk
over 4 years ago
Preview
0
0

No Worries! CAD Risk Disclosure OK at Alzheimer's Genotyping

It's "psychologically safe" to divulge extra information about risk for preventable diseases when genotyping for Alzheimer's disease; but it's premature to recommend APOE4 screening, experts say.  
medscape.com
over 4 years ago
Preview
0
1

Screening Picks Up Early CRC With Better Chance of Survival

Bowel and other cancers detected with screening are more than twice as likely to be stage I cancers than those detected by a general practitioner or emergency presentation, new findings suggest.  
medscape.com
over 4 years ago
Preview
0
1

Fecal Immunochemical Test Screening Effective at 4 Years

Fecal immunochemical test screening was accurate and accepted in a large community colorectal cancer screening program after 4 years of annual testing.  
medscape.com
over 4 years ago
Preview
0
0

Palpation for Thyroid Nodules in Cancer Survivors Saves $$

A standardized step-wise approach for detecting thyroid cancer in a high-risk population is effective and eliminates the need for routine ultrasound screening, with huge cost savings.  
medscape.com
over 4 years ago
Preview
0
0

New Depression Screening Guidelines Released

New US Preventive Services Task Force recommendations call for depression screening at the primary care level for all adults, adding pregnancy and the postpartum period.  
medscape.com
over 4 years ago
Preview
0
0

Inappropriate Cancer Screening Prevalent in People Over 65

Nonrecommended screening tests for prostate cancer and breast cancer were conducted on 15.7% of people older than 65 years.  
medscape.com
over 4 years ago
Preview
0
0

US panel recommends depression screening for all adults

The US Preventive Services Task Force has recommended that all adults aged 18 years and older be screened for depression, including pregnant and postpartum women.  
feeds.bmj.com
over 4 years ago
Preview
0
0

US panel recommends depression screening for all adults

The US Preventive Services Task Force has recommended that all adults aged 18 years and older be screened for depression, including pregnant and postpartum women.  
feeds.bmj.com
over 4 years ago
Preview
0
0

Detection of ductal carcinoma in situ and subsequent interval cancers

The recent report by Stephen Duffy and colleagues sheds light on the relation between the detection of ductal carcinoma in situ (DCIS) and subsequent interval cancer rates.1 Using data from the UK National Health Service Breast Screening Programme (NHSBSP), the authors report on detection rates of DCIS in women aged 50-69 across four years (2003-07). They also report on interval cancer detection rates in the 36 months after the index screen and examine the effect of detecting DCIS on subsequent interval cancer rates. They estimate that, for DCIS detection rates up to 1.5 per 1000 women screened, there is one fewer invasive interval cancer over the subsequent three years for every three cases of DCIS.  
feeds.bmj.com
over 4 years ago
Preview
0
0

1 in 7 Colorectal Cancers Found in Younger Patients

The prevalence of colorectal cancer is increasing in patients younger than the age for routine screening, and they are presenting with more advanced disease.  
medscape.com
over 4 years ago
Preview
0
0

Millions of Women at Risk for Alcohol-Exposed Pregnancies

The CDC urges physicians to conduct regular alcohol screening and talk with women about birth control. The latest report shows 75% of women who want to get pregnant as soon as possible are drinking.  
medscape.com
over 4 years ago
Preview
0
1

Otitis Media: New Guideline Includes Screening At-Risk Kids

Medical therapies should not be used, including antibiotics and nasal steroid sprays, according to updated American Academy of Otolaryngology-Head and Neck Surgery Foundation guidelines.  
medscape.com
over 4 years ago
Preview
0
0

Office Visits Prior to Screening Colonoscopy Add to Medical Costs

Office visits prior to screening colonoscopy add to medical costs, and it's unclear whether those visits are necessary, researchers report.  
medscape.com
over 4 years ago
Preview
0
2

Pharmacogenetic Testing for 5-FU Saves Lives and Money

Prospective screening for a genetic variant of DPD, an enzyme that catabolizes 5-FU, reduces mortality from 10% to 0% in patients with this variant and is cost-effective. Dr David Kerr is all for it.  
medscape.com
over 4 years ago